The Role of gdT Cell Therapies in Autoimmunity
Time: 1:45 pm
day: Conference Day Two - Track A - PM
Details:
- An alternative to CD19 targeting
- Identifying and removing autoreactive B cells by directlytargeting the B cell activating factor receptors
- Eliminating the cause of inflammation at the source
